"All In' -- Good News for California's $56 Million Investment in Search for Diabetes Cure
A $56 million bet by the state of California on a diabetes cure is showing additional promise that it will ultimately pay off.
The latest indication came last week when Big Pharma’s Johnson & Johnson went “all in” on ViaCyte, Inc., which has received $56 million from the California stem cell agency during the last 11 years, surpassing the amount that UC …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.